| 95% CrI | Probability that Treatment Shows Small, Moderate or Large Improvement Relative to Placebo* | |||||
|---|---|---|---|---|---|---|
| Treatment (mg) | ES** | Low | High | Small | Moderate | Large |
| acetaminophen 4000 | -0.04 | -0.20 | 0.13 | 0.03 | 0 | 0 |
| nsNSAIDs | ||||||
| naproxen 1000 | -0.37 | -0.51 | -0.23 | 0.99 | 0.04 | 0.00 |
| ibuprofen 2400 | -0.41 | -0.64 | -0.18 | 0.96 | 0.22 | 0.00 |
| diclofenac 150 | -0.52 | -0.70 | -0.33 | >0.99 | 0.58 | 0.00 |
| COX-2 selective NSAIDs | ||||||
| celecoxib 100 | -0.15 | -0.35 | 0.06 | 0.30 | 0.00 | 0.00 |
| celecoxib 200 | -0.34 | -0.42 | -0.27 | >0.99 | 0.00 | 0.00 |
| celecoxib 400 | -0.26 | -0.43 | -0.09 | 0.74 | 0.00 | 0.00 |
| lumiracoxib 100 | -0.32 | -0.48 | -0.15 | 0.92 | 0.02 | 0.00 |
| lumiracoxib 200 | -0.35 | -0.52 | -0.17 | 0.95 | 0.04 | 0.00 |
| lumiracoxib 400 | -0.36 | -0.53 | -0.20 | 0.97 | 0.05 | 0.00 |
| etoricoxib 30 | -0.61 | -0.76 | -0.46 | >0.99 | 0.93 | 0.01 |
| etoricoxib 60 | -0.64 | -0.83 | -0.46 | >0.99 | 0.93 | 0.05 |